Additionally, Liu et al. demonstrated that genetic variants in PPAR pathway genes, particularly MED1, PRKCA, and PRKCB, may contribute to susceptibility to pancreatic cancer [181]. The gene discussed is MED1; the disease is pancreatic neoplasm.